← SynDRA
PERGOLIDE
SynDRA canonical compound SYN0000653 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | HTR2C |
|---|
| Mechanism of action | Dopamine receptor agonist |
|---|
All known targets
- DRD1
- DRD2
- DRD5
- DRD4
- DRD3
- HTR1D
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR1B
- ADRA2C
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD2 AGONIST
- DRD3 AGONIST
- DRD5 AGONIST
- DRD4 AGONIST
- DRD1 AGONIST
- DRD1 MODULATOR
- DRD2 MODULATOR
Drug classes
- Dopamine Agonists
- Dopamine Agents
- Neurotransmitter Agents
- Ergot-derived Dopamine Receptor Agonist
ATC classes
- N04B · DOPAMINERGIC AGENTS
Cross-references
Synonyms
- LY-127,809
- LY127,809
- permax
- LY 127809
- pergolide mesilate
- pergolide mesylate
- Pergolida
- Pergolidum
- Permax
- Pergolida [INN-Spanish]
- Pergolide (INN)
- Pergolide [INN:BAN]
- Pergolidum [INN-Latin]
- Permax (TN)
- (6aR,9R,10aR)-9-(Methylthiomethyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
- (8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline
- (8beta)-8-[(methylthio)methyl]-6-propylergoline
- CHEBI:63617
- Parkotil
- Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-
- RefChem:57298
- DTXCID203438
- N04BC02
- 8beta-[(Methylthio)methyl]-6-propylergoline
- PERGOLIDE [INN]
- LY 141B
- NCGC00017366-04
- TNP00315
- UNII-24MJ822NZ9
- SR-01000721840
- Spectrum_001647
- PERGOLIDE [MI]
- Prestwick0_000295
- Prestwick1_000295
- Prestwick2_000295
- Prestwick3_000295
- Spectrum2_001970
- Spectrum3_001588
Look up PERGOLIDE in the interactive SynDRA portal →